General Atlantic-backed biotech start-up secures $410mn in initial funding round

General Atlantic-backed biotech start-up secures $410mn in initial funding round

FT.com

Published

Verdiva Bio wants to use potential drugs acquired in China to compete in growing obesity market

Full Article